Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Interferon Alfa-2a and Ribavirin in Korean CHC
NCT01596517Phase 4Completed
- Sponsor
- Asan Medical Center
- Start
- Jun 2003
- Primary completion
- Dec 2011
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a in hepatitis C (HCV), sponsored by Asan Medical Center. Started Jun 2003; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01596517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01596517.